Biovie (BIVI) Stock: Why It's Down Today
Updated Oct 20, 2026, 1:16 PM ET · intraday price
- Trading at $1.25 as of 1:16 PM ET, -8.39% vs the prior close of $1.37.
- Volume 228.25K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)
BIVI slides 8.4% to $1.25. Trading at $1.25 (intraday, 1:16 PM ET), -8.39% vs the prior close of $1.37. Day range $1.24–$1.45, opened at $1.40.
BIVI daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — BIVI slides 8.4% to $1.25
- Trading at $1.25 (intraday, 1:16 PM ET), -8.39% vs the prior close of $1.37. Day range $1.24–$1.45, opened at $1.40.
- Volume was 228.25K shares, 0.0x its 50-day average of 5.59M — lighter than usual.
- Price is -23.8% vs its 50-day average ($1.65) and -17.2% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; the current price sits at 15% of that range, 66.9% below the 52-week high.
Oct 19, 2026 — BIVI jumps 14.2% to $1.37
- Closed at $1.37, +14.17% vs the prior close of $1.20. Day range $1.20–$1.39, opened at $1.23.
- Volume was 182.38K shares, 0.0x its 50-day average of 5.65M — lighter than usual.
- Price is -16.7% vs its 50-day average ($1.64) and -9.6% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; today's close sits at 19% of that range, 63.9% below the 52-week high.
Oct 16, 2026 — BIVI jumps 6.2% to $1.20
- Closed at $1.20, +6.19% vs the prior close of $1.13. Day range $1.12–$1.22, opened at $1.13.
- Volume was 275.33K shares, 0.0x its 50-day average of 5.82M — lighter than usual.
- Price is -26.7% vs its 50-day average ($1.64) and -20.8% vs its 200-day average ($1.51).
- 52-week range $0.82–$3.79; today's close sits at 13% of that range, 68.3% below the 52-week high.
Oct 15, 2026 — BIVI dips 2.6% to $1.13, a 1-month low, 4 down days in a row
- Closed at $1.13, -2.59% vs the prior close of $1.16. Day range $1.13–$1.19, opened at $1.18.
- Volume was 166.90K shares, 0.0x its 50-day average of 5.82M — lighter than usual.
- Price is -31.1% vs its 50-day average ($1.64) and -25.4% vs its 200-day average ($1.51).
- 52-week range $0.82–$3.79; today's close sits at 10% of that range, 70.2% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — BIVI slides 3.3% to $1.16, a 1-month low, 3 down days in a row
- Closed at $1.16, -3.33% vs the prior close of $1.20. Day range $1.15–$1.25, opened at $1.20.
- Volume was 342.60K shares, 0.1x its 50-day average of 5.83M — lighter than usual.
- Price is -30.0% vs its 50-day average ($1.66) and -23.4% vs its 200-day average ($1.51).
- 52-week range $0.82–$3.79; today's close sits at 11% of that range, 69.4% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — BIVI slides 9.1% to $1.20, a 1-month low
- Closed at $1.20, -9.09% vs the prior close of $1.32. Day range $1.20–$1.33, opened at $1.30.
- Volume was 171.90K shares, 0.0x its 50-day average of 5.82M — lighter than usual.
- Price is -28.2% vs its 50-day average ($1.67) and -20.8% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; today's close sits at 13% of that range, 68.3% below the 52-week high.
Oct 12, 2026 — BIVI slides 5.0% to $1.32
- Closed at $1.32, -5.04% vs the prior close of $1.39. Day range $1.31–$1.44, opened at $1.41.
- Volume was 67.30K shares, 0.0x its 50-day average of 5.83M — lighter than usual.
- Price is -21.4% vs its 50-day average ($1.68) and -12.9% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; today's close sits at 17% of that range, 65.2% below the 52-week high.
Oct 9, 2026 — BIVI jumps 8.6% to $1.39
- Closed at $1.39, +8.59% vs the prior close of $1.28. Day range $1.27–$1.40, opened at $1.30.
- Volume was 204.80K shares, 0.0x its 50-day average of 5.83M — lighter than usual.
- Price is -17.4% vs its 50-day average ($1.68) and -8.3% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; today's close sits at 19% of that range, 63.3% below the 52-week high.
Oct 8, 2026 — BIVI slides 8.6% to $1.28, a 1-month low, 13 down days in a row
- Closed at $1.28, -8.57% vs the prior close of $1.40. Day range $1.25–$1.39, opened at $1.37.
- Volume was 362.20K shares, 0.1x its 50-day average of 5.82M — lighter than usual.
- Price is -24.0% vs its 50-day average ($1.68) and -15.5% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; today's close sits at 15% of that range, 66.2% below the 52-week high.
- That makes 13 straight losses.
Oct 7, 2026 — BIVI dips 2.8% to $1.40, a 1-month low, 12 down days in a row
- Closed at $1.40, -2.78% vs the prior close of $1.44. Day range $1.40–$1.47, opened at $1.46.
- Volume was 134.60K shares, 0.0x its 50-day average of 5.82M — lighter than usual.
- Price is -16.9% vs its 50-day average ($1.68) and -7.7% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; today's close sits at 20% of that range, 63.1% below the 52-week high.
- That makes 12 straight losses.
Oct 6, 2026 — BIVI ends flat (+0.0%) to $1.44, 11 down days in a row
- Closed at $1.44, +0.00% vs the prior close of $1.44. Day range $1.44–$1.50, opened at $1.44.
- Volume was 132.60K shares, 0.0x its 50-day average of 5.82M — lighter than usual.
- Price is -14.4% vs its 50-day average ($1.68) and -5.0% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; today's close sits at 21% of that range, 62.0% below the 52-week high.
- That makes 11 straight losses.
Oct 5, 2026 — BIVI dips 1.4% to $1.44, a 1-month low, 10 down days in a row
- Closed at $1.44, -1.37% vs the prior close of $1.46. Day range $1.42–$1.48, opened at $1.43.
- Volume was 135.00K shares, 0.0x its 50-day average of 5.82M — lighter than usual.
- Price is -14.3% vs its 50-day average ($1.68) and -5.0% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; today's close sits at 21% of that range, 62.0% below the 52-week high.
- That makes 10 straight losses.
Oct 2, 2026 — BIVI dips 0.7% to $1.46, a 1-month low, 9 down days in a row
- Closed at $1.46, -0.68% vs the prior close of $1.47. Day range $1.46–$1.52, opened at $1.47.
- Volume was 189.90K shares, 0.0x its 50-day average of 5.82M — lighter than usual.
- Price is -13.1% vs its 50-day average ($1.68) and -3.7% vs its 200-day average ($1.52).
- 52-week range $0.82–$3.79; today's close sits at 22% of that range, 61.5% below the 52-week high.
- That makes 9 straight losses.
BIVI bull case vs bear case (from the data)
- Insiders made 16 open-market purchases in the last 12 months.
- Price is -23.8% vs its 50-day average — short-term trend is down.
- Price is -17.2% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $22.07M.
- High volatility: average daily move of 4.0% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
BIVI latest news & SEC filings
Every SEC filing by or about BIVI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 14, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 3, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Palumbo Joseph M bought 4,843 shares at $2.16 (≈$10.46K) on Aug 28, 2026
- Palumbo Joseph M bought 4,843 shares at $2.16 (≈$10.46K) on Aug 28, 2026
- Palumbo Joseph M bought 4,843 shares at $2.16 (≈$10.46K) on Aug 28, 2026
- Palumbo Joseph M bought 4,843 shares at $2.16 (≈$10.46K) on Aug 28, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chappell Amy Suzon bought 727 shares at $2.16 (≈$1.57K) on Aug 28, 2026
- Chappell Amy Suzon bought 727 shares at $2.16 (≈$1.57K) on Aug 28, 2026
- Chappell Amy Suzon bought 727 shares at $2.16 (≈$1.57K) on Aug 28, 2026
- Chappell Amy Suzon bought 727 shares at $2.16 (≈$1.57K) on Aug 28, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kim Joanne Wendy bought 2,500 shares at $2.18 (≈$5.45K) on Aug 28, 2026
- Kim Joanne Wendy bought 2,500 shares at $2.18 (≈$5.45K) on Aug 28, 2026
- Kim Joanne Wendy bought 2,500 shares at $2.18 (≈$5.45K) on Aug 28, 2026
- Kim Joanne Wendy bought 2,500 shares at $2.18 (≈$5.45K) on Aug 28, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Do Cuong V bought 15,210 shares at $2.08 (≈$31.64K) on Aug 27, 2026
- Do Cuong V bought 15,210 shares at $2.08 (≈$31.64K) on Aug 27, 2026
- Do Cuong V bought 15,210 shares at $2.08 (≈$31.64K) on Aug 27, 2026
- Do Cuong V bought 15,210 shares at $2.08 (≈$31.64K) on Aug 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form S-1/A — S-1/A filing
S-1/A filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 13, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Net income: -$22.07M (prior year -$17.54M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$3.05 (prior year -$12.12) (loss narrowed vs Jun 30, 2025)
Aug 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form FWP — Free writing prospectus (offering marketing material)
Free writing prospectus (offering marketing material)
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 6, 2026 · Form FWP — Free writing prospectus (offering marketing material)
Free writing prospectus (offering marketing material)
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade BIVI
- How much it moves: over the last 20 sessions the average daily move was 4.05% (largest 14.2%). That is a volatile stock.
- Liquidity: about 215.00K shares (≈$269.82K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.25 vs a range of $0.82–$3.79 (15% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Jul 7, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: Joanne Wendy Kim bought 2,500 shares on Aug 28, 2026.
- Latest filings: 8-K Sep 14, 2026; 10-K Aug 13, 2026; 8-K Aug 6, 2026.
- Share count: 7.54M shares outstanding (Aug 10, 2026), +0.1% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BIVI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 1.40 | 1.45 | 1.24 | 1.25 | 228.25K |
| Oct 19, 2026 | 1.29 | 1.39 | 1.20 | 1.37 | 182.40K |
| Oct 16, 2026 | 1.13 | 1.22 | 1.12 | 1.20 | 275.40K |
| Oct 15, 2026 | 1.18 | 1.19 | 1.13 | 1.13 | 166.90K |
| Oct 14, 2026 | 1.20 | 1.25 | 1.15 | 1.16 | 342.60K |
| Oct 13, 2026 | 1.30 | 1.33 | 1.20 | 1.20 | 171.90K |
| Oct 12, 2026 | 1.41 | 1.44 | 1.31 | 1.32 | 67.30K |
| Oct 9, 2026 | 1.30 | 1.40 | 1.27 | 1.39 | 204.80K |
| Oct 8, 2026 | 1.37 | 1.39 | 1.25 | 1.28 | 362.20K |
| Oct 7, 2026 | 1.46 | 1.47 | 1.40 | 1.40 | 134.60K |
| Oct 6, 2026 | 1.44 | 1.50 | 1.44 | 1.44 | 132.60K |
| Oct 5, 2026 | 1.43 | 1.48 | 1.42 | 1.44 | 135.00K |
| Oct 2, 2026 | 1.47 | 1.52 | 1.46 | 1.46 | 189.90K |
| Oct 1, 2026 | 1.53 | 1.53 | 1.46 | 1.47 | 266.00K |
| Sep 30, 2026 | 1.57 | 1.58 | 1.50 | 1.52 | 201.30K |
| Sep 29, 2026 | 1.55 | 1.61 | 1.52 | 1.54 | 145.30K |
| Sep 28, 2026 | 1.57 | 1.60 | 1.53 | 1.54 | 182.50K |
| Sep 25, 2026 | 1.66 | 1.75 | 1.58 | 1.61 | 458.70K |
| Sep 24, 2026 | 1.60 | 1.64 | 1.60 | 1.61 | 235.80K |
| Sep 23, 2026 | 1.63 | 1.66 | 1.59 | 1.63 | 216.50K |
About Biovie
Biovie (BIVI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CARSON CITY, NV. State of incorporation: NV. Fiscal year ends June 30. SEC CIK 1580149.
BIVI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Amy Suzon Chappell | Director | Aug 28, 2026 |
| Cuong V Do | President & CEO | Aug 28, 2026 |
| Kameel D. Farag | Director | Jan 9, 2026 |
| James Paul Lang | Director | Jan 9, 2026 |
| Sigmund Rogich | Director | Jan 9, 2026 |
| Michael Edward Sherman | Director | Jan 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Cuong V Do | President & CEO | Aug 28, 2026 |
| Joanne Wendy Kim | Chief Financial Officer | Aug 28, 2026 |
| Joseph M Palumbo | Chief Medical Officer | Aug 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Joanne Wendy Kim | Buy | 2,500 | $2.18 |
| Aug 28, 2026 | Joanne Wendy Kim | Buy | 2,500 | $2.18 |
| Aug 28, 2026 | Joanne Wendy Kim | Buy | 2,500 | $2.18 |
| Aug 28, 2026 | Joanne Wendy Kim | Buy | 2,500 | $2.18 |
| Aug 28, 2026 | Joseph M Palumbo | Buy | 4,843 | $2.16 |
| Aug 28, 2026 | Joseph M Palumbo | Buy | 4,843 | $2.16 |
| Aug 28, 2026 | Joseph M Palumbo | Buy | 4,843 | $2.16 |
| Aug 28, 2026 | Joseph M Palumbo | Buy | 4,843 | $2.16 |
| Aug 28, 2026 | Amy Suzon Chappell | Buy | 727 | $2.16 |
| Aug 28, 2026 | Amy Suzon Chappell | Buy | 727 | $2.16 |
| Aug 28, 2026 | Amy Suzon Chappell | Buy | 727 | $2.16 |
| Aug 28, 2026 | Amy Suzon Chappell | Buy | 727 | $2.16 |
| Aug 27, 2026 | Cuong V Do | Buy | 15,210 | $2.08 |
| Aug 27, 2026 | Cuong V Do | Buy | 15,210 | $2.08 |
| Aug 27, 2026 | Cuong V Do | Buy | 15,210 | $2.08 |
BIVI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | — | $-22.07M | -3.05 | $-19.02M |
| Jun 30, 2025 | — | $-17.54M | -12.12 | $-19.03M |
| Jun 30, 2024 | — | $-32.12M | -73.05 | $-27.95M |
| Jun 30, 2023 | — | $-50.26M | -15.47 | $-40.25M |
| Jun 30, 2022 | — | $-26.08M | -1.06 | $-18.99M |
Latest balance sheet: total assets $14.25M, total liabilities $3.98M, cash $8.98M (as of Jun 30, 2026).
BIVI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)United Therapeutics (UTHR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BIVI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 1:16 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.